1 ene 2007 año - Food and Drug Administration Amendments Act of 2007
Descripción:
Specifically authorized FDA to require manufacturers post-marketing clinical studies to monitor for risks infected during the pre-market approval process
Also required REMS programs where necessary. What is a REMS program?
Añadido al timeline:
fecha:
1 ene 2007 año
Ahora mismo
~ 18 years ago